help button home button
AJRCMB
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Garayoa, M.
Right arrow Articles by Mulshine, J. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Garayoa, M.
Right arrow Articles by Mulshine, J. L.
American Journal of Respiratory Cell and Molecular Biology. Vol. 28, pp. 80-85, 2003
© 2003 American Thoracic Society
DOI: 10.1165/rcmb.4880

Downregulation of hnRNP A2/B1 Expression in Tumor Cells under Prolonged Hypoxia

Mercedes Garayoa, Yan-Gao Man, Alfredo Martínez, Frank Cuttitta and James L. Mulshine

Cell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; Department of Histology and Pathology, Carcinogenesis Unit, University of Navarra, Pamplona, Spain; and Department of Gynecologic and Breast Pathology, Armed Forces Institute of Pathology, Washington DC.

Address correspondence to: Dr. James L. Mulshine, Intervention Section, Cell and Cancer Biology Branch, CCR, NCI, NIH, Bldg. 10, Room 12N226, 9000 Rockville Pike, Bethesda, MD 20892-1906. E-mail: mulshinj{at}mail.nih.gov

Heterogeneous nuclear ribonucleoprotein (hnRNP) A2/B1 has been previously shown to be overexpressed in breast and lung tumors. Because hypoxia is a feature inherent in solid tumors, the regulation of hnRNP A2/B1 expression and subcellular localization under hypoxic conditions was studied on human lung and breast carcinoma cell lines. We found that sustained hypoxic treatment downregulated hnRNP A2/B1 expression in MCF7 and H157 cell lines. Northern blot analysis showed that this decay: (i) was observed as a marked diminution of transcript levels after 24–48 h of exposure to low oxygen tension; (ii) is not mediated by the transcription factor, hypoxia inducible factor-1; and (iii) is partially dependent on a higher hnRNP A2/B1 messenger RNA turnover under hypoxic than normoxic conditions. Immunocytochemical staining also showed a significant diminution of hnRNP A2/B1 staining in these cell lines after 24–48 h of hypoxia, together with a predominant loss of cytoplasmic staining. Further investigations are warranted to evaluate the relevance of modulation of hnRNP A2/B1 in hypoxic environments relative to its previously reported utility as a marker of early lung carcinogenesis.

Abbreviations: adenosine uridine, AU • deoxycytosinetriphosphate, dCTP • deformed epidermal autoregulatory factor-1, DEAF-1 • hypoxia-inducible factor 1, HIF-1 • heterogeneous nuclear ribonucleoprotein, hnRNP • messenger RNA, mRNA • 3' untranslated region, 3'UTR







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Proc. Am. Thorac. Soc. Am. J. Respir. Crit. Care Med.
Copyright © 2003 American Thoracic Society.
  ATS Best of the Web